Recent advances in the discovery of anti-breast cancer agents based on dual-target inhibition strategies.
This review systematically summarizes advancements over the past five years in the construction of dual-target anticancer agents using mainstream strategies, including pharmacophore fusion and scaffold hopping and highlights typical dual-target candidates involved in epigenetic remodeling, synthetic lethality coupled w...